CERRITO MARIA GRAZIA

Ilari, A., Grassilli, E., Mauri, M., Cazzaniga, M., Capici, S., Lavitrano, M., et al. (2026). Metronomic 5-Fluorouracil and Vinorelbine Reduce Cancer Stemness and Modulate EZH2/NOTCH-1/STAT3 Signaling in Triple-Negative Breast Cancer Spheroids. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 27(1) [10.3390/ijms27010123]. Dettaglio

Ilari, A., Cogliati, V., Sherif, N., Grassilli, E., Ramazzotti, D., Cordani, N., et al. (2024). Differential Expression of NOTCH-1 and Its Molecular Targets in Response to Metronomic Followed by Conventional Therapy in a Patient with Advanced Triple-Negative Breast Cancer. BIOMEDICINES, 12(2) [10.3390/biomedicines12020272]. Dettaglio

Grassilli, E., Cerrito, M. (2023). "Ironing out" fasting-induced persister cancer cells to render chemotherapy effective: is this the solution?. EBIOMEDICINE, 90(April 2023) [10.1016/j.ebiom.2023.104542]. Dettaglio

Grassilli, E., Cerrito, M., Bonomo, S., Giovannoni, R., Conconi, D., and Lavitrano, M. (2023). Targeting p65BTK for treating solid cancers. Intervento presentato a: 6th world cancer research, Lisbona. Dettaglio

Cordani, N., Mologni, L., Piazza, R., Tettamanti, P., Cogliati, V., Mauri, M., et al. (2023). TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24(22) [10.3390/ijms242216294]. Dettaglio